Botulinum toxin A for aesthetic contouring of enlarged medial gastrocnemius muscle

Dermatologic Surgery

Volumn 30, Issue 6, 2004, Pages 867-871

  Lee, Hyun Jeong ^a   Lee, Dong Won ^a   Park, Yeon Ho ^a   Cha, Mi Kyung ^a   Kim, Hong Sik ^a   Ha, Seog Jun ^a   Tsai, Ren Yeu ^a   Chan, Henry H L ^b  

^a University of Hong Kong ^*

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; FUNCTIONAL ASSESSMENT; GASTROCNEMIUS MUSCLE; HUMAN; LEG MUSCLE; MEDICAL PHOTOGRAPHY; MUSCLE ATROPHY; MUSCLE HYPERTROPHY; PRIORITY JOURNAL; SENSORIMOTOR FUNCTION; SKELETAL MUSCLE; TREATMENT OUTCOME;

EID: 2942642874     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2004.30255.x     Document Type: Article

References (16)

1. Korezyn AD, Kuritzky A, Sandbank U. Muscle hypertrophy with neuropathy. J Neurol Sci 1978;38:399-408.
2. Pearn J, Hudgson P. Anterior-horn cell degeneration and gross calf hypertrophy with adolescent onset: a new spinal muscular atrophy syndrome. Lancet 1978;1:1059-61.
3. Valenstein E, Watson RT, Parker JL. Myokymia, muscle hypertrophy and percussion 'myotonia' in chronic recurrent polyneuropathy. Neurology 1978;28:1130-4.
4. Bertorini TE, Igarashi M. Postpoliomyelitis muscle pseudohypertrophy. Muscle Nerve 1985;8:644-9.
5. Kim IG, Hwang SH, Lew JM, Lee HY. Endoscope-assisted calf reduction in Orientals. Plast Reconstr Surg 2000;106:713-20.
6. Tsai CC, Lee SS, Lai CS, Lin SD, Chiou CS. Aesthetic resection of the gastrocnemius muscle in postpoliomyelitis calf hypertrophy: an uncommon case report. Aesthetic Plast Surg 2001;25:111-3.
7. Lemperle G, Exner K. The resection of gastrocnemius muscles in aesthetically disturbing calf hypertrophy. Plast Reconstr Surg 1998; 102:2230-6.
8. Coert JH, Dellon AL. Clinical implications of the surgical anatomy of the sural nerve. Plast Reconstr Surg 1994;94:850-5.
9. To EW, Ahuja AT, Ho WS, et al. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg 2001;54:197-200.
10. von Lindern JJ, Niederhagen B, Appel T, Berge S, Reich RH. Type A botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscles: an alternative treatment. Plast Reconstr Surg 2001;107:327-32.
11. Finn S, Ryan P, Sleeman D. The medical management of masseteric hypertrophy with botulinum toxin. J Ir Dent Assoc 2000;46:84-6.
12. Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 1990;53:633-9.
13. Brin MF. Interventional neurology: treatment of neurological conditions with local injection of botulinum toxin. Arch Neurobiol (Madr) 1991; 54(Suppl 3):7-23.
14. Osako M, Keltner JL. Botulinum A toxin (oculinum) in ophthalmology. Surv Ophthalmol 1991;36:28-46.
15. Jankovic J, Brin MF. Botulinum toxin: historical perspective and potential new indications. Muscle Nerve Suppl 1997;6:129-45.
16. Tsai CC, Lin SD, Lai CS, Lin TM. Aesthetic analysis of the ideal female legs. Aesth Plast Surg 2000;24:303-5.